Praxis Precision Medicines (PRAX) Securities - Tradable: 2022-2025
Historic Securities - Tradable for Praxis Precision Medicines (PRAX) over the last 3 years, with Sep 2025 value amounting to $239.6 million.
- Praxis Precision Medicines' Securities - Tradable fell 1.19% to $239.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $239.6 million, marking a year-over-year decrease of 1.19%. This contributed to the annual value of $254.2 million for FY2024, which is N/A change from last year.
- According to the latest figures from Q3 2025, Praxis Precision Medicines' Securities - Tradable is $239.6 million, which was down 17.15% from $289.2 million recorded in Q2 2025.
- In the past 5 years, Praxis Precision Medicines' Securities - Tradable ranged from a high of $306.9 million in Q2 2024 and a low of $5.0 million during Q1 2023.
- Moreover, its 3-year median value for Securities - Tradable was $248.3 million (2024), whereas its average is $220.9 million.
- As far as peak fluctuations go, Praxis Precision Medicines' Securities - Tradable tumbled by 96.56% in 2023, and later surged by 2,381.54% in 2024.
- Praxis Precision Medicines' Securities - Tradable (Quarterly) stood at $38.9 million in 2022, then plummeted by 96.56% to $5.0 million in 2023, then surged by 2,381.54% to $254.2 million in 2024, then dropped by 1.19% to $239.6 million in 2025.
- Its last three reported values are $239.6 million in Q3 2025, $289.2 million for Q2 2025, and $306.5 million during Q1 2025.